An Open Label Study of CM-AT for the Treatment of Children With Autism
NCT02649959
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
405
Enrollment
INDUSTRY
Sponsor class
Conditions
Autism
Interventions
DRUG:
CM-AT
Sponsor
Curemark